Роль суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии

1. Manchia G. Clinical use of ambulatory blood pressure. Am J Hyperttens 1989; 2: 505–45.
2. Di Rienzo M, Parati G, Pomidossi G et al. Blood pressure monitoring over short day and night time cannot predict 24-hour average blood pressure. J Hypertens 1985; 3: 343–9.
3. Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. Суточное мониторирование артериального давления (Методические вопросы). Под ред. Г.Г.Арабидзе, О.Ю.Атькова. М., 1997.
4. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Комитет экспертов Всероссийского научного общества кардиологов. Секция артериальной гипертонии ВНОК. М., 2004. Приложение к журналу "Кардиоваскулярная терапия и профилактика".
5. Fratolla A, Parati G, Cuspidi С et al. Prognostic value of 24-hour pressure variability. J Hypertens 1993; 11: 1133–7.
6. Redon J, Gomez-Sanchez M, Baldo E et al. Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens 1991; 9: 148–9.
7. McMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74.
8. White W. Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991; 9: 27–32.
9. White W. Accuracy and analysis of ambulatory blood pressure monitoring data. Clin Cardiolog 1992; 15: 10–3.
10. Zachariah P, Sheps S, Bailey K et al. Ambulatory blood pressure and blood pressure load in 121-normal subjects. Am J Hypertens 1989; 2: 58.
11. Imai Y, Abe K, Munakata M et al. Circadian blood pressure variations under different pathophysiological conditions. J Hypertens 1990; 8: 125–32.
12. Kario K, Matsuo Т, Kobayashi H et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension 1996; 27: 130–5.
13. Dodt С, Breckling U, Derad I et al. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30: 71–6.
14. Somers V, Dyken M, Mark A et al. Autonomic and hemodynamic responses during sleep in normal and sleep-apneic humans. J Hypertens 1992; 10: 4.
15. Staessen J, Bieniaszewski L, O'Brien E et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. Hypertension 1997; 29: 30–9.
16. Prager G, Prager R, Klein P. Comparison of the twenty-four-hour blood pressure profile in elderly subjects with isolated systolic hypertension, essential hypertension and normotension. J Hypertens Suppl 1991; 9 (6): 102–3.
17. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens 1997; 10: 261–8.
18. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988; 2: 327.
19. Manchia G, Bertinieri G. Mechanisms of blood pressure measurements variability in man. Clin and exper.-theory and practice. 1985; 7: 167–78.
20. Langdon CG, Packard RS. Doxazosin in hypertension: Results of a general practice study in 4809 patients. Brit J Clin Pract 1994; 48: 293–8.
21. Pickering Th, Harshfield G, Blank S et al. Behavioral determinants of 24 hour blood pressure patterns in borderline hypertension. J Cardiovasc Pharmacol 1986; 8: 589–59.
22. Willich SN, Levy D, Rocco MB et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801–6.
23. Schillaci G, Verdecchia P, Benemio G, Porcellati C. Blood pressure rise and ischemic stroke. Lancet 1995; 346: 1366–7.
24. Kapiotis S, Jilma B, Quehenberger P et al. Morning hypercoagulability and hypofibrinolysis: diurnal variations in circulating activated factor Vll, prothrombin fragment Fl+2, and plasmin-plasmin inhibitor complex. Circulation 1997; 96: 19–21.
25. Carmona J, Vasconcelos N, Amado P et al. Blood pressure morning rise profile in hypertensive patients and controls evaluated by ambulatory blood pressure monitoring. Abstracts of the 7th European meeting on hypertension. 1992; 33.
26. Kannel W. Potency of vascular risk factors as the basis for antihypertensive therapy. Framingham study. Eur Heart J 1992; 13: 34–42.
27. O’Brien E, Murhy J, Tyndall A et al. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: The Allied Irish Bank Study. J Hypertens 1991; 9: 355–60.
28. Meredith P, Perloff D, Mancia G, Picketing T. Blood pressure variability and its implication for antihypertensive therapy. Blood Press 1995; 4: 5–11.
29. Weber MA. White coat hypertension: a new definition. Cardiovasc Druds Ther 1993; 7: 421.
30. Ольбинская Л.И., Хапаев Б.А. Оценка стабильности эффекта и безопасности антигипертензивной терапии. Клин. фармакол. и тер. 1998; 3: 25–7.

И.Е.Чазова, Л.Г.Ратова

Российский кардиологический научно-производственный комплекс Росздрава, Москва